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The objective of the research was to give a comparative characteristic of parameters of humoral and cellular immunity in the
development of secondary and tertiary peritonitis.
Materials and methods. The research enrolled 109 patients with secondary peritonitis, 20 of whom developed tertiary
peritonitis. Changes in humoral and cellular immunity were evaluated by serial blood tests for the determination of leukocyte
count, the relative number of lymphocytes, Ig A, M, and G levels, as well as by counting the phagocytic index, the phagocytic
number and the leukocyte intoxication index. The statistical processing of the obtained data was made using the STATISTICA
5.0 software (StatSoft, USA).
Results. All the patients were divided into 2 groups: the group of patients with secondary peritonitis (n=89) and the group
of patients with tertiary peritonitis (n=20). In the development of tertiary peritonitis, leukocytosis, relative lymphocytopenia
and high values of the leukocyte intoxication index persisted during the entire observation period. In tertiary peritonitis, the
phagocytic index was significantly lower only on the day of hospitalization. In the group of tertiary peritonitis, the phagocytic
number decreased significantly until the 7th day after surgery. Ig A, M and G levels were lower since admission and
subsequently decreased as compared to the results in the group of patients with secondary peritonitis.
Conclusions. 1. Tertiary peritonitis is the most severe form of abdominal sepsis with high rates of mortality and rather
difficult early diagnosis. 2. With the development of tertiary peritonitis, leukocytosis increases and relative lymphocytopenia
develops. 3. The reduction in phagocytic index is indicative for the prognosis of tertiary peritonitis. 4. Ig A and M levels are
significantly lower, and the leukocyte intoxication index is high at the time of hospitalization in patients who subsequently
develop tertiary peritonitis.
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Problem statement and analysis of the
recent research
For decades, abdominal sepsis remains an actual and still
unresolved problem of emergency surgery [1, 2]. Present
contradictions in the approaches to diagnosis and treatment
of its most frequent manifestation - secondary peritonitis (SP)
– indicate its special complexity [3, 4]. The nature of the
immune response, as one of the leading components of the
pathogenesis of sepsis, allows the surgeon to evaluate not only
the efficacy of treatment, but also to predict the further course
of the disease [5, 6, 7, 8]. Nowadays, the patient’s immune
status in tertiary peritonitis (TP) is not sufficiently studied and
requires in-depth analysis, namely from the perspective of
prediction of changes in its parameters [9, 10].
The objective of the research was to give a comparative
characteristic of parameters of humoral and cellular immunity
in the development of SP and TP.
1. Materials and methods
We had prospectively examined 109 patients with SP, operated
on in the Clinic of Surgery and Endoscopy of Lviv Danylo
Halytsky National Medical University (surgical departments
No 1 and 3, Lviv City Emergency Hospital) in 2010-2015.
Etiology of SP was as follows: acute destructive appendicitis
(29.4%), perforated gastric (11%) or duodenal (7.3%) ulcer,
perforated colon cancer (11%), perforated colonic divertic-
ulitis (6.5%), abdominal abscess perforation (5.6%), acute
destructive cholecystitis with perforation (4.7%), thrombosis
of the superior mesenteric artery with small intestine necrosis
(3.6%), perforated stomach cancer (3.6%), Crohn’s disease
with the small intestine perforation (3.6%), hernia strangula-
tion with small intestine necrosis (2.8%), severe polytrauma
with injury of the small intestine (2.8%), retroperitoneal tumor
disintegration and pus formation with its perforation to the
abdomen (1.8%), ingrowth of uterine tumor into the small
intestine and subsequent necrosis (0.9%), pancreatic necro-
sis (0.9%), volvulus of the sigmoid colon with perforation
(0.9%), ulcerative colitis with necrosis of the colon (0.9%),
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perforated cancer of the small intestine (0.9%), pancreatic
cancer disintegration (0.9%), gastric perforation by a foreign
body (0.9%). Concomitant diseases were diagnosed in 88
(80.7%) patients. Women slightly prevailed – 57 (52.3%).
The age of patients was in the range of 18-88 (median - 61).
Postoperatively, majority of patients (68; 62.4%) stayed for
1-4 days (median – 2 days) in intensive care unit (ICU). Peri-
tonitis was local non-separated in 104 (95.4%) patients and
diffuse - in 88 (80.7%) patients. Postoperative complications
arose in 18 (16.5%) cases, being purulent-septic in 50% of
patients. Tertiary peritonitis was diagnosed on the 3rd-12th
days (median – 5 days) in 20 (18.3%) patients. Criteria for
diagnosis of TP were: the persistence of peritoneal symptoms
despite the adequate surgical elimination of the infectious
focus, the presence of nosocomial microflora (Citrobacter
Freundii, Acinetobacter Baumannii, Staphylococcus viridans,
Pseudomonas spp., Candida spp., Geotrichum candidum) in
peritoneal exudate, multi-organ failure (MOF) and stay in ICU
> 3 days [11]. Postoperative mortality in the whole cohort
of patients was 30.2%. Tertiary peritonitis resulted in a fatal
outcome in 90% of cases with sepsis as the main cause.
The determination of leukocyte count and the relative
number of lymphocytes was carried out by counting them in
Goryaev camera using light microscopy [12]. The leukocyte
intoxication index (LII) was calculated using the formula of
V.K. Ostrovsky [13]. Quantitative determination of Ig levels
was carried out by radial immunodiffusion by the Mancini
method with monospecific Ig A, M, and G serums [12]. The
phagocytic index (PI) and as well as the phagocytic number
(PN) was calculated by the A.N. Mayansky - D.N. Mayansky
method [14].
In order to assess immune changes in the development of
both types of peritonitis, serially (at admission, on the 3rd and
7th days thereafter; in the group of TP – on the day of diagno-
sis of TP and on the 2nd consecutive day) blood sampling was
performed to determine the absolute number of leukocytes,
the relative number of lymphocytes, the levels of Ig A, M and
G, LII, as well as PI and PC were calculated. The statistical
processing of the material was made using the STATISTICA
5.0 software (StatSoft, USA). Before choosing the method of
intergroup comparison of parametric indicators or repeated
researches, the Shapiro-Wilk test to assess distribution nor-
mality was performed. Due to non-Gaussian distribution in
groups, parametric data were presented as median, minimum-
maximum and lower-upper quartiles (25-75%).
2. Results and discussion
All the patients were divided into 2 groups: the group of
patients with SP (n=89) and the group of patients with TP
(n=20).
In the group of patients with SP, the absolute number of
leukocytes decreased as patients recovered. Perioperatively,
this indicator showed a tendency (p=0.073) towards higher
values in the group of patients with TP (median - 11·109/L
(min 4.5 - max 30.4) vs. 13.1·109/L (min 8.6 - max 36.6). In
the group of patients with TP, the number of leukocytes in-
creased being significantly higher on the 3rd (12.2·109/L (min
4 - max 21.2) vs. 10.1·109/L (min 4.6 - max 24) in the group
of patients with SP; p<0.05) and on the 7th (11.7·109/L (min
5.9 - max 24.4) vs. 8.95·109/L (min 4.5 - max 25.8) in the
group of patients with SP, p<0.001) days after surgery. Ac-
cording to another research, in most cases, the clinical course
of TP is accompanied by leukocytosis [15], which is consis-
tent with our data. Most patients with TP may develop only
leukocytosis and hyperthermia while other typical symptoms
of infection may be absent [2].
The intergroup comparison of the relative number of lym-
phocytes showed that in the group of patients with TP, it was
significantly lower throughout the entire observation period:
at admission - 13.0% (min 2 - max 30) vs. 16% (min 2 -
max 37) (p<0.05), on the 3rd day - 15% (min 6 - max 29) vs.
17% (min 3 - max 35) (p<0.05) and on the 7th day - 13.5%
(min 3 - max 28) vs. 17% (min 3 - max 35) (p<0.01). In the
group of patients with TP, lymphocytopenia was confirmed
during the entire observation period. Both intensive (compen-
satory) anti-inflammatory reaction of the organism and stress
dyshormonosis, which, in particular, leads to lymphocytope-
nia were proven to promote immunoparalysis [16].
The LII calculation revealed statistically significant differ-
ences between the comparison groups as well. The LII was
significantly (p<0.05) higher in the group of patients with
TP - 8.15 (min 4.1 - max 10.9) vs. 5.4 (min 2.2 - max 12.1)
already on the day of hospitalization. Later, in contrast to the
LII in the group of patients with SP, in patients with TP, it was
substantially (p<0.001) higher: 8.55 (min 5.6 - max 10.1) vs.
5.6 (min 2.7 - max 12.1) on the 3rd day and 6.3 (min 4.7 - max
11.3) vs. 3.9 (min 1.7 - max 10.8) on the 7th day. In the group
of patients with SP, the LII demonstrated downward dynamics.
In uncomplicated postoperative course of peritonitis, the LII
gradually decreases [17].
The indicators of phagocytic activity had their own pecu-
liarities in each of the comparison groups. At admission, in the
group of patients with TP, the PI was significantly (p<0.05)
lower, as compared to that in patients with SP: 95.25% (min
89 - max 99.2) vs. 97.1% (min 81.4 - max 99.9). Subse-
quently, in the group of patients with TP, its value did not
significantly differ (p>0.05): 95.55% (min 73 - max 99) vs.
94.7% (min 57 - max 98.7) on the 3rd day; 93.25% (min 68 -
max 97.6) vs. 93.25% (min 68 - max 97.6) on the 7th day. In
both groups, the PI decreased over time.
However, the PN did not show significant (p>0.05) inter-
group differences within the first days after surgery: perioper-
atively, in the group of patients with SP, it equaled 9.7% (min
8.4 - max 13.2) vs. 9.7% (min 8.9 - max 10.3) as compared to
patients with TP on the 3rd day - 9.5% (min 5.4 - max 13.4)
vs. 9.4% (min 7.2 - max 10.5). The significant difference
(p<0.05) in the values of the PN was found in patients with
TP on the 7th day: 9.4% (min 8.7 - max 13.1) vs. 9.1% (min
5.6 - max 17.7). In both groups, the PN gradually decreased.
The peak values of the PI and the PN in peritonitis were ob-
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served on the 7th day, which coincides with the results of our
research [7].
Ig levels differed in different monitoring periods depend-
ing on their class. In the group of patients with TP, perioper-
ative Ig A concentration tended (p=0.055) to be lower than
that in patients with SP: 6.85 g/L (min 4.8 - max 9.4) vs. 7.8
g/L (min 3.2 -max 18.7). In the following days, there were no
significant differences in Ig A values between the groups: 6.4
g/L (min 4.1 - max 16.9) vs. 6.5 g/L (min 4.3 - max 10.1) in
patients with TP (p>0.05), on the 7th day - 4.8 g/L (min 1.4 -
max 12) vs. 5.7 g/L (min 3.7 - max 7.1) in patients with TP
(p>0.05). The indicators of Ig A in both groups demonstrated
a gradual decrease with time.
Ig M levels had significant intergroup differences in all
observation days, in particular towards the lower values in
patients with TP. Ig M concentration in this group was 4.65
g/L (min 3.3 - max 6.5) (in patients with SP - 5.4 g/L (min 2.1
- max 11.1), p<0.001) on the day of admission; 4 g/L (min
2.9 - max 5.1) (in patients with SP - 5.1 g/L (min 2.8 - max
12), p<0.001) on the 3rd day; 3.3 g/L (min 1.8 - max 7.5) (in
patients with SP - 3.9 g/L (min 1.1 - max 12.4), p<0.05) on
the 7th day. Similarly to Ig A, Ig M levels demonstrated a
gradual decrease in each of the groups as well.
On the day of admission, Ig G levels between the groups
did not differ (p>0.05): 21.75 g/L (min 15.4 - max 29.1) in
patients with TP vs. 21.1 g/L (min 6.8 - max 34.5) in patients
with SP. Since the 3rd day, in the group of patients with TP,
the level of Ig G decreased significantly (p<0.001): 16.25 g/L
(min 9.5 - max 20.5) vs. 19.4 g/L (min 10.9 - max 32.9). The
same significant (p<0.05) difference was observed on the 7th
day as well: 10.2 g/L (min 4.2 - max 24.3) vs. 13.7 g/L (min
4.8 - max 40.2). In general, Ig G levels decreased irrespective
of peritonitis type.
In comparison with our results, such dynamics was ob-
served in SP. Ig A levels decrease in peritonitis and for some
time after its surgical treatment [18]. According to our data,
such changes were observed in all classes of Ig in both SP
and TP. The decrease in the concentration of major classes
of Ig are considered the indications for immunocorrection to
improve the results of sepsis treatment [19].
Peculiar changes in immunity in abdominal sepsis were
investigated by other clinicians as well. The available liter-
ature, however, does not contain the description of changes
in studied parameters in TP. The predictive nature of changes
in the investigated parameters of the immune response in TP
can be effectively used in the early prediction of the risk of its
development.
3. Conclusions
• TP is the most severe form of abdominal sepsis with
high rates of mortality and rather difficult early diagno-
sis.
• With the development of TP, leukocytosis increases and
relative lymphocytopenia develops.
• The reduction in the PI is indicative for the prognosis
of TP.
• Ig A and Ig M levels are significantly lower, and the
LII is high at the time of hospitalization in patients who
subsequently develop TP.
4. Prospects for further research
It is reasonable to assess the practical significance of changes
in immunity parameters for TP development.
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